Myomo (MYO) Long-Term Investments (2022 - 2023)
Myomo (MYO) reported Long-Term Investments of $32648.0 for Q3 2023, down 78.11% on a YoY basis from $149140.0 in Q3 2022, and down 68.23% quarter-over-quarter from $102773.0 in Q2 2023.
Myomo (MYO) Long-Term Investments (2022 - 2023) Analysis & Trends
Myomo has reported Long-Term Investments for 2 years, with the latest figure at $32648.0 in Q3 2023.
- For the quarter ending Q3 2023, Long-Term Investments fell 78.11% year-over-year to $32648.0; the trailing twelve-month figure through Sep 2023 stood at $32648.0 (down 78.11% YoY), and the FY2022 full-year result was $132489.0, changed N/A from the prior year.
- Long-Term Investments for Q3 2023 stood at $32648.0, down from $102773.0 in the prior quarter.
- The five-year high for Long-Term Investments was $199000.0 in Q1 2022, with the low at $32648.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 32,648.00 |
| Jun 30, 2023 | 102,773.00 |
| Mar 31, 2023 | 115,287.00 |
| Dec 31, 2022 | 132,489.00 |
| Sep 30, 2022 | 149,140.00 |
| Jun 30, 2022 | 165,792.00 |
| Mar 31, 2022 | 199,000.00 |